Quick Answer
Abivax S.A. reported Total Assets of $584.34 million for fiscal year 2025.
Abivax S.A. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $584.34M | +184.7% |
| 2024 | $205.23M | -37.3% |
| 2023 | $327.06M | +332.9% |
| 2022 | $75.54M | -30.8% |
| 2021 | $109.23M | — |
- Abivax S.A. showed an increase of +184.7% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Abivax S.A.’s total assets has grown by 435.0% (from $109.23 million to $584.34 million).
- The most recent figure is from Abivax S.A.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: